Our finding revealed that overexpression of LYRM2 decreased the level of epithelial marker while increased the level of mesenchymal markers, indicating that LYRM2 promotes HCC metastasis through regulating EMT phenotype. The gene discussed is LYRM2; the disease is hepatocellular carcinoma.